FULC / Fulcrum Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Fulcrum Therapeutics, Inc.
US ˙ NasdaqGM ˙ US3596161097

Utestående aksjer 54,091,588 shares
Innsideraksjer33 804 692 shares
Eierandel blant insidere62,50 %
Totale insidere43
Insider Sentiment Score

Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.

Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.

Officer Sentiment Score

Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.

Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.

Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.

Nøkkelindikatorer for insidere

Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.

For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).

Netto antall insidere som kjøper (Rangering)

0 ( )

2134 out of 11314

Nettotall av innsidekjøp som kjøper er det totale antallet insidere som har kjøpt minus det totale antallet insidere som har solgt de siste 90 dagene. Den prosentvise rangeringen vises her (rangerer fra 0 til 100%).

Prosent av aksjeflyt kjøpt av insidere (rang)

0.000 %( )

2099 out of 11237

Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.

Diagram over innsidehandel

Fulcrum Therapeutics, Inc. insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.

Insiderliste og lønnsomhetsmålinger

Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.

See our leaderboard of most profitable insider traders.

Innsider Gjennomsnittlig fortjeneste (%) Aksjer
eid
Splitt
justert
6 Dimensions Capital, L.P. 10% Owner - [10%] 559 821 559 821
Santiago Arroyo Chief Medical Officer - [O] 0 0
Sonja Banks Director - [D] 0 0
Diego Cadavid SVP Clinical Development - [O] 65 714 65 714
Casdin Capital, LLC 10% Owner - [10%] 604 285 604 285
Eli Casdin 10% Owner - [10%] 604 285 604 285
Casdin Partners GP, LLC 10% Owner - [10%] 604 285 604 285
Casdin Partners Master Fund, L.P. 10% Owner - [10%] 604 285 604 285
Collins James J. Director - [D] 47 142 47 142
Katina Dorton Director - [D] 0 0
Judith Dunn See Remarks - [O] 0 0
Alan Ezekowitz Director - [D] 57 854 57 854
James A Geraghty Director - [D] 90 714 90 714
Plc Glaxosmithkline 10% Owner - [10%] 1 785 714 1 785 714
Innsider Gjennomsnittlig fortjeneste (%) Aksjer
eid
Splitt
justert
Robert J Gould Interim President & CEO, Director - [D] [O] 499 864 499 864
Kate Haviland 9 285
Hayes Melvin H. III Chief Operating Officer - [O] 0 0
Colin Hill Director - [D] 0 0
Patrick Taylor Horn Chief Medical Officer - [O] 0 0
Mark J Levin Director, 10% Owner - [D] [10%] 3 962 202 3 962 202
William J Maris 10% Owner - [10%] 464 285 464 285
Christopher Morabito Chief Medical Officer - [O] 1 100 1 100
Christopher Moxham Chief Scientific Officer - [O] 0 0
Alan A Musso Chief Financial Officer - [O] 0 0
Curtis Gale Oltmans SVP, General Counsel - [O] 1 248 1 248
Ra Capital Management, Llc 10% Owner - [10%] 20 458 198 20 458 198
Esther Rajavelu Chief Financial Officer - [O] 0 0
Kevin P Starr 10% Owner - [10%] 3 962 202 3 962 202
Innsider Gjennomsnittlig fortjeneste (%) Aksjer
eid
Splitt
justert
Sanofi 10% Owner - [10%] 558 035 558 035
Alex Sapir See Remarks, Director - [D] [O] 193 360 193 360
Section 32 Fund 2, LP 10% Owner - [10%] 464 285 464 285
Section 32 GP 2, LLC 10% Owner - [10%] 464 285 464 285
Bryan Stuart See Remarks, Director - [D] [O] 0 0
Robert I Tepper 10% Owner - [10%] 3 962 202 1 962 202
Trv Gp Iii, Llc 10% Owner - [10%] 3 962 202 1 962 202
Trv Gp Iv, Llc 10% Owner - [10%] 2 343 154 2 343 154
Third Rock Ventures GP III, L.P. 10% Owner - [10%] 3 962 202 1 962 202
Third Rock Ventures GP IV, L.P. 10% Owner - [10%] 2 343 154 2 343 154
Third Rock Ventures III, L.P. 10% Owner - [10%] 1 962 202 1 962 202
Third Rock Ventures IV, L.P. 10% Owner - [10%] 2 343 154 2 343 154
Thomson Peter G. VP Finance & Accounting - [O] 2 300 2 300
Greg Tourangeau Principal Accounting Officer - [O] 14 062 14 062
Wallace Owen B. Chief Scientific Officer - [O] 133 438 133 438

Report errors via our new Insider Auditing Tool

Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse

I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i FULC / Fulcrum Therapeutics, Inc.. Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.

Handelsdato Innsider Rapporterte
aksjer
Rapportert
pris
Justert
aksjer
Justert
pris
Kostnadsgrunnlag Dager til
maks
Pris ved
maks
Maks
fortjeneste
Maks avkastning (%)
2024-03-04 Sapir Alex 43 360 11,3475 43 360 11,3475 492 028 2 12.0000 28 293 5,75
2023-01-20 RA CAPITAL MANAGEMENT, LLC 1 923 076 13,0000 1 923 076 13,0000 24 999 988
2023-01-04 RA CAPITAL MANAGEMENT, LLC 122 334 7,0276 122 334 7,0276 859 714
2023-01-04 RA CAPITAL MANAGEMENT, LLC 58 369 7,7968 58 369 7,7968 455 091
2022-12-27 RA CAPITAL MANAGEMENT, LLC 4 089 5,9941 4 089 5,9941 24 510
2022-12-19 RA CAPITAL MANAGEMENT, LLC 98 787 5,8997 98 787 5,8997 582 814
2022-12-16 RA CAPITAL MANAGEMENT, LLC 1 341 420 5,4195 1 341 420 5,4195 7 269 826
2022-12-15 RA CAPITAL MANAGEMENT, LLC 237 029 5,4950 237 029 5,4950 1 302 474
2022-12-14 RA CAPITAL MANAGEMENT, LLC 824 600 5,4591 824 600 5,4591 4 501 574

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

FULC / Fulcrum Therapeutics, Inc. Insider Trades
Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse

I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i FULC / Fulcrum Therapeutics, Inc.. Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.

Handelsdato Innsider Rapporterte
aksjer
Rapportert
pris
Justert
aksjer
Justert
pris
Kostnadsgrunnlag Dager til
min
Pris ved
min
Maks tap
ungått ($)
Maks tap
ungått (%)
2025-05-08 Tourangeau Greg 498 5,0600 498 5,0600 2 520 1 5.3700 155 6,16
2024-05-07 Tourangeau Greg 236 7,7600 236 7,7600 1 831
2024-03-08 Tourangeau Greg 4 884 11,7155 4 884 11,7155 57 219
2023-05-10 Tourangeau Greg 210 3,3100 210 3,3100 695

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

FULC / Fulcrum Therapeutics, Inc. Insider Trades
Transaksjonshistorikk

Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.

Fil
dato
Handels
dato
Skjema Innsider Ticker Verdipapirnavn Kode 10b5-1 Direkte Utøvelses
pris
Enhets
pris
Enheter
endret
Verdi
endret (1K)
Gjenværende
Opsjoner
Gjenværende
Aksjer
2025-05-09 2025-05-08 4 Tourangeau Greg FULC Common Stock S - Sale D 5,0600 −498 −3 14 062
2024-09-23 3 RA CAPITAL MANAGEMENT, LLC See footnotes FULC Common Stock I 10 229 099
2024-08-23 2024-08-21 4 RA CAPITAL MANAGEMENT, LLC See footnotes FULC Common Stock J - Other I −8 500 000 3 109 704
2024-07-08 2024-07-03 4 Sapir Alex FULC Common Stock M - Exercise D 3,2700 150 000 490 193 360
2024-06-18 3 Hill Colin FULC No securities are beneficially owned D 0
2024-05-09 2024-05-07 4 Tourangeau Greg FULC Common Stock S - Sale D 7,7600 −236 −2 11 571
2024-03-20 3 Horn Patrick Taylor FULC No securities are beneficially owned D 0
2024-03-08 2024-03-08 4 Tourangeau Greg FULC Common Stock S - Sale D 11,7155 −4 884 −57 11 807
2024-03-05 2024-03-04 4 Sapir Alex FULC Common Stock P - Purchase D 11,3475 43 360 492 43 360
2023-08-09 3 Musso Alan A FULC No securities are beneficially owned D 0
2023-05-11 2023-05-10 4 Tourangeau Greg FULC Common Stock S - Sale D 3,3100 −210 −1 15 992
2023-01-24 2023-01-20 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 13,0000 1 923 076 25 000 11 609 704
2023-01-13 2023-01-13 4 Gould Robert J FULC Common Stock S - Sale D 15,0000 −6 766 −101 499 864
2023-01-06 2023-01-04 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 7,7968 58 369 455 9 686 628
2023-01-06 2023-01-04 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 7,0276 122 334 860 9 628 259
2022-12-29 2022-12-27 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,9941 4 089 25 9 505 925
2022-12-21 2022-12-19 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,8997 98 787 583 9 501 836
2022-12-16 2022-12-16 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,4195 1 341 420 7 270 9 403 049
2022-12-16 2022-12-15 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,4950 237 029 1 302 8 061 629
2022-12-16 2022-12-14 4 RA CAPITAL MANAGEMENT, LLC See Footnotes FULC Common Stock P - Purchase I 5,4591 824 600 4 502 7 824 600
2022-12-15 2022-12-13 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D −2 000 000 1 962 202
2022-11-09 3 Arroyo Santiago FULC No securities are beneficially owned D 0
2022-08-26 3 Shah Rajeev M. FULC Common Stock I 7 000 000
2022-08-11 3 Hayes Melvin H. III FULC No securities are beneficially owned D 0
2022-06-08 2022-06-07 4 Gould Robert J FULC Common Stock S - Sale D 8,0898 −71 435 −578 506 630
2022-06-08 2022-06-07 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 71 435 560 578 065
2022-06-06 2022-06-06 4 Gould Robert J FULC Common Stock S - Sale D 8,1040 −24 382 −198 506 630
2022-06-06 2022-06-06 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 24 382 191 531 012
2022-06-06 2022-06-03 4 Gould Robert J FULC Common Stock S - Sale D 7,9471 −25 551 −203 506 630
2022-06-06 2022-06-03 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 25 551 200 532 181
2022-06-06 2022-06-02 4 Gould Robert J FULC Common Stock S - Sale D 7,9191 −16 689 −132 506 630
2022-06-06 2022-06-02 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 16 689 131 523 319
2022-05-10 2022-05-06 4 Tourangeau Greg FULC Stock Option (right to buy) A - Award D 8,63 6 500 6 500
2022-05-10 2022-05-06 4 Tourangeau Greg FULC Common Stock A - Award D 3 250 16 202
2022-04-11 2022-04-07 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 −5 631 224 580
2022-04-11 2022-04-07 4 Gould Robert J FULC Common Stock S - Sale D 24,0150 −5 631 −135 506 630
2022-04-11 2022-04-07 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 5 631 44 512 261
2022-04-05 2022-04-05 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 −52 552 230 211
2022-04-05 2022-04-05 4 Gould Robert J FULC Common Stock S - Sale D 24,2574 −52 552 −1 275 506 630
2022-04-05 2022-04-05 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 52 552 412 559 182
2022-04-05 2022-04-04 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 −7 235 282 763
2022-04-05 2022-04-04 4 Gould Robert J FULC Common Stock S - Sale D 24,0151 −7 235 −174 506 630
2022-04-05 2022-04-04 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 7 235 57 513 865
2022-04-05 2022-04-01 4 Gould Robert J FULC Stock Option (right to buy) M - Exercise D 7,84 −34 464 289 998
2022-04-05 2022-04-01 4 Gould Robert J FULC Common Stock S - Sale D 24,0297 −34 464 −828 506 630
2022-04-05 2022-04-01 4 Gould Robert J FULC Common Stock M - Exercise D 7,8400 34 464 270 541 094
2022-03-14 3 Tourangeau Greg FULC Common Stock D 12 952
2022-01-21 2022-01-19 4 Morabito Christopher FULC Stock Option (right to buy) A - Award D 12,69 59 744 59 744
2022-01-21 2022-01-19 4 Oltmans Curtis Gale FULC Stock Option (right to buy) A - Award D 12,69 60 000 60 000
2022-01-21 2022-01-19 4 Dunn Judith FULC Stock Option (right to buy) A - Award D 12,69 140 890 140 890
2022-01-21 2022-01-19 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 12,69 340 000 340 000
2022-01-21 2022-01-19 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 12,69 40 000 40 000
2022-01-10 2022-01-03 4 Rajavelu Esther FULC Stock Option (right to buy) A - Award D 17,82 200 000 200 000
2022-01-10 3 Rajavelu Esther FULC No securities are beneficially owned D 0
2022-01-07 2021-12-17 5 Oltmans Curtis Gale FULC Common Stock G - Gift D −1 088 1 248
2021-12-09 2021-12-08 4 Banks Sonja FULC Stock Option (right to buy) A - Award D 15,73 30 000 30 000
2021-12-09 3 Banks Sonja FULC No securities are beneficially owned D 0
2021-11-12 2021-11-10 4 LEVIN MARK J FULC Common Stock J - Other I −1 000 000 3 962 202
2021-11-12 2021-11-10 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D −1 000 000 3 962 202
2021-09-24 2021-09-22 4 Third Rock Ventures III, L.P. FULC Common Stock J - Other D −1 000 000 4 962 202
2021-09-24 2021-09-22 4 LEVIN MARK J FULC Common Stock J - Other I −1 000 000 4 962 202
2021-08-12 2021-08-11 4 Stuart Bryan FULC Stock Option (right to buy) M - Exercise D 7,84 −28 000 243 571
2021-08-12 2021-08-11 4 Stuart Bryan FULC Common Stock S - Sale D 23,7500 −28 000 −665 0
2021-08-12 2021-08-11 4 Stuart Bryan FULC Common Stock M - Exercise D 7,8400 28 000 220 28 000
2021-08-12 2021-08-10 4 Stuart Bryan FULC Stock Option (right to buy) M - Exercise D 7,84 −32 000 271 571
2021-08-12 2021-08-10 4 Stuart Bryan FULC Common Stock S - Sale D 17,5000 −32 000 −560 0
2021-08-12 2021-08-10 4 Stuart Bryan FULC Common Stock M - Exercise D 7,8400 32 000 251 32 000
2021-08-12 2021-08-10 4 Moxham Christopher FULC Stock Option (right to buy) M - Exercise D 7,84 −31 071 72 501
2021-08-12 2021-08-10 4 Moxham Christopher FULC Stock Option (right to buy) M - Exercise D 7,84 −20 714 103 572
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stockm S - Sale D 18,0000 −31 071 −559 0
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock M - Exercise D 7,8400 31 071 244 31 071
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock S - Sale D 17,0000 −20 714 −352 0
2021-08-12 2021-08-10 4 Moxham Christopher FULC Common Stock M - Exercise D 7,8400 20 714 162 20 714
2021-06-29 2021-06-28 4 Thomson Peter G. FULC Common Stock P - Purchase I 9,0000 2 300 21 2 300
2021-06-29 2021-06-28 4 Oltmans Curtis Gale FULC Common Stock P - Purchase D 9,0100 1 088 10 1 088
2021-06-29 2021-06-28 4 Morabito Christopher FULC Common Stock P - Purchase D 9,1600 1 100 10 1 100
2021-06-29 2021-06-28 4 GERAGHTY JAMES A FULC Common Stock P - Purchase D 9,1600 10 000 92 90 714
2021-06-11 2021-06-09 4 Collins James J. FULC Stock Option (right to buy) A - Award D 8,85 15 000 15 000
2021-06-11 2021-06-09 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 8,85 15 000 15 000
2021-06-11 2021-06-09 4 LEVIN MARK J FULC Stock Option (right to buy) A - Award D 8,85 15 000 15 000
2021-06-11 2021-06-09 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 8,85 15 000 15 000
2021-06-11 2021-06-09 4 Dorton Katina FULC Stock Option (right to buy) A - Award D 8,85 15 000 15 000
2021-06-11 2021-06-09 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 8,85 15 000 15 000
2021-05-12 2021-05-10 4 Morabito Christopher FULC Stock Option (right to buy) A - Award D 10,01 163 000 163 000
2021-05-12 3 Morabito Christopher FULC No securities are beneficially owned D 0
2021-04-02 2021-04-01 4 Dunn Judith FULC Stock Option (right to buy) A - Award D 12,00 215 000 215 000
2021-04-02 2021-03-31 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 11,78 350 000 350 000
2021-04-02 3 Dunn Judith FULC No securities are beneficially owned D 0
2021-03-17 2021-03-16 4 Gould Robert J FULC Common Stock S - Sale D 12,4279 −789 −10 506 630
2021-03-17 2021-03-15 4 Gould Robert J FULC Common Stock S - Sale D 12,1347 −9 211 −112 507 419
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Stock Option (right to buy) M - Exercise D 7,84 −5 000 50 471
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Common Stock S - Sale D 14,7163 −5 000 −74 15 212
2021-02-24 2021-02-22 4 Thomson Peter G. FULC Common Stock M - Exercise D 7,8400 5 000 39 20 212
2021-02-18 2021-02-16 4 Gould Robert J FULC Common Stock S - Sale D 14,5649 −1 673 −24 516 630
2021-02-18 2021-02-16 4 Gould Robert J FULC Common Stock S - Sale D 14,1899 −6 542 −93 518 303
2021-02-10 2021-02-08 4 Moxham Christopher FULC Stock Option (right to buy) A - Award D 12,60 100 000 100 000
2021-02-10 3 Moxham Christopher FULC No securities are beneficially owned D 0
2021-02-04 2021-02-02 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 11,33 269 390 269 390
2021-01-27 2021-01-25 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 13,09 40 000 40 000
2021-01-27 2021-01-25 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 13,09 134 376 134 376
2021-01-25 2021-01-21 4 Thomson Peter G. FULC Common Stock S - Sale D 14,0000 −6 607 −92 15 212
2021-01-22 2021-01-20 4 Gould Robert J FULC Common Stock S - Sale D 12,0826 −10 000 −121 524 845
2020-12-07 2020-12-03 4 Oltmans Curtis Gale FULC Stock Option (right to buy) A - Award D 11,82 153 600 153 600
2020-12-07 2020-12-03 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 11,82 15 000 15 000
2020-12-07 3 Oltmans Curtis Gale FULC No securities are beneficially owned D 0
2020-09-14 2020-09-14 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 −6 350 75 592
2020-09-14 2020-09-14 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 6 350 50 133 438
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 −2 951 81 942
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 −2 951 −59 127 088
2020-07-09 2020-07-08 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 2 951 23 130 039
2020-07-09 2020-07-08 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 −2 500 −50 534 845
2020-07-02 2020-07-01 4 Cadavid Diego FULC Common Stock S - Sale D 18,3000 −1 071 −20 65 714
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 −141 84 893
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 −141 −3 127 088
2020-07-01 2020-06-30 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 141 1 127 229
2020-06-26 2020-06-25 4 Gould Robert J FULC Common Stock S - Sale D 20,7968 −2 500 −52 537 345
2020-06-26 2020-06-25 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −1 459 12 277
2020-06-26 2020-06-25 4 Cadavid Diego FULC Common Stock S - Sale D 22,0000 −1 459 −32 66 785
2020-06-26 2020-06-25 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 1 459 7 68 244
2020-06-15 2020-06-11 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 17,63 9 285 9 285
2020-06-15 2020-06-11 4 Collins James J. FULC Stock Option (right to buy) A - Award D 17,63 9 285 9 285
2020-06-15 2020-06-11 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 17,63 9 285 9 285
2020-06-15 2020-06-11 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 17,63 9 285 9 285
2020-06-15 2020-06-11 4 LEVIN MARK J FULC Stock Option (right to buy) A - Award D 17,63 9 285 9 285
2020-06-12 2020-06-10 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −401 13 736
2020-06-12 2020-06-10 4 Cadavid Diego FULC Common Stock S - Sale D 22,0000 −401 −9 66 785
2020-06-12 2020-06-10 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 401 2 67 186
2020-06-10 2020-06-09 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 −156 −3 539 845
2020-06-09 2020-06-05 4 Gould Robert J FULC Common Stock S - Sale D 20,1722 −3 433 −69 540 001
2020-06-08 2020-06-05 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −451 14 137
2020-06-08 2020-06-05 4 Cadavid Diego FULC Common Stock S - Sale D 20,1791 −451 −9 66 785
2020-06-08 2020-06-05 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 451 2 67 236
2020-06-08 2020-06-04 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −226 14 588
2020-06-08 2020-06-04 4 Cadavid Diego FULC Common Stock S - Sale D 20,0498 −226 −5 66 785
2020-06-08 2020-06-04 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 226 1 67 011
2020-06-05 2020-06-04 4 Gould Robert J FULC Common Stock S - Sale D 20,0446 −1 300 −26 543 434
2020-06-05 2020-06-03 4 Gould Robert J FULC Common Stock S - Sale D 20,1283 −1 500 −30 544 734
2020-06-04 2020-06-03 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −338 14 814
2020-06-04 2020-06-03 4 Cadavid Diego FULC Common Stock S - Sale D 20,1763 −338 −7 66 785
2020-06-04 2020-06-03 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 338 2 67 123
2020-06-04 2020-06-02 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −45 15 152
2020-06-04 2020-06-02 4 Cadavid Diego FULC Common Stock S - Sale D 20,0000 −45 −1 66 785
2020-06-04 2020-06-02 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 45 0 66 830
2020-06-03 2020-06-02 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 −2 797 −56 546 234
2020-06-03 2020-06-01 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 −5 −0 549 031
2020-06-01 2020-05-29 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −200 15 197
2020-06-01 2020-05-29 4 Cadavid Diego FULC Common Stock S - Sale D 20,0350 −200 −4 66 785
2020-06-01 2020-05-29 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 200 1 66 985
2020-06-01 2020-05-28 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −600 15 397
2020-06-01 2020-05-28 4 Cadavid Diego FULC Common Stock S - Sale D 20,0000 −600 −12 66 785
2020-06-01 2020-05-28 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 600 3 67 385
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 −2 232 85 034
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 −2 232 −45 127 088
2020-06-01 2020-05-28 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 2 232 17 129 320
2020-06-01 2020-05-29 4 Gould Robert J FULC Common Stock S - Sale D 20,0797 −1 390 −28 549 036
2020-06-01 2020-05-28 4 Gould Robert J FULC Common Stock S - Sale D 20,0058 −1 919 −38 550 426
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 −448 87 266
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 −448 −9 127 088
2020-05-29 2020-05-27 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 448 4 127 536
2020-05-28 2020-05-26 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 −2 500 −50 552 345
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 −412 87 714
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 −412 −8 127 088
2020-05-28 2020-05-26 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 412 3 127 500
2020-05-12 2020-05-11 4 Thomson Peter G. FULC Common Stock S - Sale D 16,0000 −7 500 −120 21 071
2020-05-12 2020-05-12 4 Cadavid Diego FULC Stock Option (right to buy) M - Exercise D 4,83 −1 860 15 997
2020-05-12 2020-05-12 4 Cadavid Diego FULC Common Stock S - Sale D 18,0000 −1 860 −33 66 785
2020-05-12 2020-05-12 4 Cadavid Diego FULC Common Stock M - Exercise D 4,8300 1 860 9 68 645
2020-03-02 2020-03-02 4 Cadavid Diego FULC Common Stock S - Sale D 18,1255 −315 −6 66 785
2020-03-02 2020-03-02 4 Cadavid Diego FULC Common Stock S - Sale D 17,2567 −1 828 −32 67 100
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 18,6120 −250 −5 28 571
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 17,4326 −2 102 −37 28 821
2020-02-26 2020-02-24 4 Thomson Peter G. FULC Common Stock S - Sale D 16,1845 −2 648 −43 30 923
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Stock Option (right to buy) M - Exercise D 7,84 −6 088 88 126
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Common Stock S - Sale D 20,0000 −6 088 −122 127 088
2020-02-20 2020-02-19 4 Wallace Owen B. FULC Common Stock M - Exercise D 7,8400 6 088 48 133 176
2020-02-20 2020-02-19 4 Gould Robert J FULC Common Stock S - Sale D 20,0000 −2 500 −50 554 845
2020-02-05 2020-02-03 4 Cadavid Diego FULC Common Stock S - Sale D 17,3317 −2 143 −37 68 928
2020-01-27 2020-01-23 4 Wallace Owen B. FULC Stock Option (right to buy) A - Award D 16,87 58 900 58 900
2020-01-27 2020-01-23 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 16,87 200 000 200 000
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 16,87 33 100 33 100
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Common Stock S - Sale D 18,0539 −262 −5 33 571
2020-01-27 2020-01-23 4 Thomson Peter G. FULC Common Stock S - Sale D 17,1743 −4 738 −81 33 833
2020-01-27 2020-01-23 4 Cadavid Diego FULC Stock Option (right to buy) A - Award D 16,87 55 440 55 440
2020-01-27 2020-01-23 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 16,87 105 000 105 000
2020-01-06 3 Dorton Katina FULC No securities are beneficially owned D 0
2020-01-06 2020-01-02 4 Dorton Katina FULC Stock Option (right to buy) A - Award D 15,86 18 571 18 571
2019-07-24 2019-07-22 4 GLAXOSMITHKLINE PLC FULC Series B Preferred Stock C - Conversion I −12 500 000 0
2019-07-24 2019-07-22 4 GLAXOSMITHKLINE PLC FULC Common Stock C - Conversion I 1 785 714 1 785 714
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Series B Preferred Stock (par value $0.001) C - Conversion I 0,00 −3 250 000 0
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Common Stock (par value $0.001) P - Purchase I 16,0000 93 750 1 500 558 035
2019-07-23 2019-07-22 4 Sanofi Through its wholly-owned subsidiary, Aventis Inc. FULC Common Stock (par value $0.001) C - Conversion I 464 285 464 285
2019-07-22 2019-07-22 4 Section 32 Fund 2, LP FULC Series B Preferred Stock C - Conversion D −3 250 000 0
2019-07-22 2019-07-22 4 Section 32 Fund 2, LP FULC Common Stock C - Conversion D 464 285 464 285
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Series A Preferred Stock C - Conversion I −39 166 667 0
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Common Stock P - Purchase I 16,0000 81 250 1 300 5 962 202
2019-07-22 2019-07-22 4 LEVIN MARK J By fund FULC Common Stock C - Conversion I 5 595 238 5 880 952
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Series B Preferred Stock C - Conversion I −3 250 000 0
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 14,4998 5 000 72 604 285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 14,4996 10 000 145 599 285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock P - Purchase I 16,0000 125 000 2 000 589 285
2019-07-22 2019-07-22 4 Casdin Capital, LLC FULC Common Stock C - Conversion I 464 285 464 285
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Series B Preferred Stock C - Conversion D −3 087 500 0
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Common Stock P - Purchase D 16,0000 118 750 1 900 559 821
2019-07-22 2019-07-22 4 6 Dimensions Capital, L.P. FULC Common Stock C - Conversion D 441 071 441 071
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Series A Preferred Stock C - Conversion D 0 0
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Series A Preferred Stock C - Conversion D −39 166 667 0
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Common Stock P - Purchase D 16,0000 81 250 1 300 5 962 202
2019-07-22 2019-07-22 4 Third Rock Ventures III, L.P. FULC Common Stock C - Conversion D 5 595 238 5 880 952
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Series A Preferred Stock C - Conversion D −15 833 333 0
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Common Stock P - Purchase D 16,0000 81 250 1 300 2 343 154
2019-07-22 2019-07-22 4 Third Rock Ventures IV, L.P. FULC Common Stock C - Conversion D 2 261 904 2 261 904
2019-07-18 2019-07-18 4 Thomson Peter G. FULC Stock Option (right to buy) A - Award D 16,00 7 078 7 078
2019-07-18 2019-07-18 4 Stuart Bryan FULC Stock Option (right to buy) A - Award D 16,00 28 571 28 571
2019-07-18 2019-07-18 4 Cadavid Diego FULC Stock Option (right to buy) A - Award D 16,00 12 784 12 784
2019-07-18 2019-07-18 4 Gould Robert J FULC Stock Option (right to buy) A - Award D 16,00 107 142 107 142
2019-07-18 2019-07-18 4 Haviland Kate FULC Stock Option (right to buy) A - Award D 16,00 9 285 9 285
2019-07-18 2019-07-18 4 Ezekowitz Alan FULC Stock Option (right to buy) A - Award D 16,00 5 714 5 714
2019-07-18 2019-07-18 4 GERAGHTY JAMES A FULC Stock Option (right to buy) A - Award D 16,00 9 285 9 285
2019-07-18 2019-07-18 4 Collins James J. FULC Stock Option (right to buy) A - Award D 16,00 5 714 5 714
2019-07-18 2019-07-18 4 Wallace Owen B. FULC Stock Option (right to buy) A - Award D 16,00 44 493 44 493
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161 428
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161 428
2019-07-17 3 GERAGHTY JAMES A FULC Common Stock D 161 428
2019-07-17 3 Collins James J. FULC Common Stock D 47 142
2019-07-17 3 Collins James J. FULC Common Stock D 47 142
2019-07-17 3 Collins James J. FULC Common Stock D 47 142
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254 176
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254 176
2019-07-17 3 Wallace Owen B. FULC Common Stock D 254 176
2019-07-17 3 Gould Robert J FULC Common Stock D 1 114 690
2019-07-17 3 Gould Robert J FULC Common Stock D 1 114 690
2019-07-17 3 Gould Robert J FULC Common Stock D 1 114 690
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77 142
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77 142
2019-07-17 3 Thomson Peter G. FULC Common Stock D 77 142
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57 854
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57 854
2019-07-17 3 Ezekowitz Alan FULC Common Stock D 57 854
2019-07-17 3 Cadavid Diego FULC Common Stock D 142 142
2019-07-17 3 Cadavid Diego FULC Common Stock D 142 142
2019-07-17 3 Cadavid Diego FULC Common Stock D 142 142
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571 428
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571 428
2019-07-17 3 LEVIN MARK J FULC Common Stock I 571 428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571 428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571 428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571 428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571 428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571 428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571 428
2019-07-17 3 TEPPER ROBERT I FULC Common Stock I 571 428
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista